CinCor Pharma to Participate at Upcoming September Investor Conferences

Rhea-AI Summary

CinCor Pharma announced participation in major investor conferences including Citi's 17th Annual BioPharma Conference from September 6-8, 2022, in Boston, MA, and Morgan Stanley’s 20th Annual Healthcare Conference on September 12-13, 2022, in New York, NY.

Additionally, management will present at the 2022 Wells Fargo Healthcare Conference on September 7, 2022, at 3:45 PM ET, with a live webcast available. Investors can arrange meetings during these events.

CinCor, established in 2018, focuses on innovative treatments for cardio-renal diseases, with lead drug baxdrostat in clinical development.

WALTHAM, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will participate at the following investor conferences: Citi's 17^th Annual BioPharma Conference taking place September 6 - 8, 2022 in Boston, MA and Morgan Stanley’s 20^th Annual Healthcare Conference, taking place September 12 - 13, 2022 in New York, NY.

Company management will also present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022 at 3:45 PM ET in Boston, MA. A link to the live webcast will be available at webcast/wellsfargo. An archived replay of the presentation will be available for 90 days at CinCor.com/events.

The CinCor management team will participate in investor meetings during each of these events. Investors interested in meeting with CinCor at the conference should contact their respective event representative.

About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.

Contacts:	Investors:
Terry Coelho	Bob Yedid
CinCor Pharma, Inc.	LifeSci Advisors
EVP, CFO and CBDO	ir@CinCor.com

                                                        

 

FAQ

What investor conferences is CinCor participating in September 2022?

CinCor will participate in Citi's 17th Annual BioPharma Conference from September 6-8, 2022, and Morgan Stanley's 20th Annual Healthcare Conference from September 12-13, 2022.

When is CinCor's presentation at the Wells Fargo Healthcare Conference?

CinCor's presentation at the 2022 Wells Fargo Healthcare Conference is scheduled for September 7, 2022, at 3:45 PM ET.

Where can I find the webcast for CinCor’s Wells Fargo presentation?

The live webcast for CinCor's presentation at the Wells Fargo Healthcare Conference can be accessed through their official site during the event.

What is the focus of CinCor Pharma's clinical development?

CinCor Pharma is focused on innovative treatments for cardio-renal diseases, with their lead drug, baxdrostat, aimed at treating hypertension and primary aldosteronism.

How can investors meet with CinCor during conferences?

Investors interested in meeting with CinCor during the conferences should contact their respective event representatives.